Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
3,267,303
-
Share change
-
-910,633
-
Total reported value
-
$1,729,000
-
Put/Call ratio
-
33%
-
Price per share
-
$0.5295
-
Number of holders
-
22
-
Value change
-
-$1,067,336
-
Number of buys
-
16
-
Number of sells
-
4
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q2 2022
As of 30 Jun 2022 IGC Pharma, Inc. - COM NEW (IGC) had 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,267,303 shares of stock of the company.
Largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, DEARBORN PARTNERS LLC, and Vident Investment Advisory, LLC.
This table shows 22 institutional shareholders of the security as of 30 Jun 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.